Losing your lab

Losing your lab In 2007, more than 4,000 NIH-funded researchers were denied grant renewals. For some,that means they have to close upshop. By Alison McCook Article Extras Web Only: Weaned, via Whitaker Other labs lost For Alan Schneyer, everything changed in June, 2006. The scientist was running a lab in the reproductive endocrinology department at Massachusetts General Hospital (MGH) in Boston, and had recently logged some interesting result

Written byAlison McCook
| 12 min read

Register for free to listen to this article
Listen with Speechify
0:00
12:00
Share

By Alison McCook

Web Only: Weaned, via Whitaker

Other labs lost

For Alan Schneyer, everything changed in June, 2006. The scientist was running a lab in the reproductive endocrinology department at Massachusetts General Hospital (MGH) in Boston, and had recently logged some interesting results from his knockout mice. The results suggested a protein with a suspected reproductive function could also have a significant effect on glucose metabolism - and, perhaps, diabetes.

However, one morning when he arrived at work and went online, he found that, to his surprise, the grant application he had submitted to explore this hypothesis had been returned, without review. For many scientists, this news would be discouraging. But for Schneyer, who was funded largely on soft money, it was much worse. It meant he had to close his lab.

The process was already slowly underway. One of Schneyer's technicians had decided to go back to school, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies